- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Vancomycin-resistant enterococcus.
Displaying page 1 of 1.
EudraCT Number: 2021-003835-28 | Sponsor Protocol Number: APHP210089 | Start Date*: 2022-02-17 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS | |||||||||||||
Full Title: Prevention of C. difficile infections with oral vancomycin in patients treated for allogeneic hematopoietic stem cell transplantation, a double-blind, randomized, placebo-controlled trial ” VANCALLO | |||||||||||||
Medical condition: Patients hospitalized for an allogeneic hematopoietic stem cell transplant | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001054-17 | Sponsor Protocol Number: PHRN15-SE/AMIKINHAL | Start Date*: 2017-01-27 | |||||||||||
Sponsor Name:CHRU de Tours | |||||||||||||
Full Title: Double-blinded multicenter randomized controlled trial comparing inhaled amikacin versus placebo to prevent ventilator associated pneumonia | |||||||||||||
Medical condition: Patient with mechanical ventilation through an endotracheal tube | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001200-12 | Sponsor Protocol Number: A5951002 | Start Date*: 2007-08-27 | |||||||||||
Sponsor Name:Pfizer Global Research and Development | |||||||||||||
Full Title: Linezolid In The Treatment Of Complicated Skin And Soft Tissue Infections Proven To Be Due To Methicillin-Resistant Staphylococcus Aureus | |||||||||||||
Medical condition: Complicated skin and soft tissue infections | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) GB (Completed) ES (Completed) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-005159-32 | Sponsor Protocol Number: A5951105 | Start Date*: 2005-04-28 | |||||||||||
Sponsor Name:Pfizer Limited | |||||||||||||
Full Title: Linezolid vs Vancomycin/Cefazolin in the treatment of hemodialysis patients with catheter-related gram-positive bloodstream infections | |||||||||||||
Medical condition: Catheter-related Gram-positive bloodstream infections. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) DE (Prematurely Ended) IT (Prematurely Ended) ES (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
